More on TLX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $9.45 |
|
|||
| Open | $9.42 | ||||
| 52 Wk High | $2.18 | ||||
| 52 Wk Low | $0.30 | ||||
| Day High | $9.60 | ||||
| Day Low | $9.42 | ||||
| P/E | N/A | ||||
| EPS | $-3.32 | ||||
| Volume | 386,782 | ||||
- Telix and United Imaging form theranostics collaboration
- Telix and United Imaging Announce Strategic Theranostics Collaboration
- Telix presents prostate cancer trial data showing acceptable safety
- ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
- JPMorgan Starts Telix Pharmaceuticals Ltd (TLX:AU) (TLX) at Overweight
- Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences
- Form 6-K Telix Pharmaceuticals For: May 20
- Form 3 Telix Pharmaceuticals For: May 11 Filed by: GILL DAVID N
- Form 3 Telix Pharmaceuticals For: May 11 Filed by: Jellison William R
- Form 3 Telix Pharmaceuticals For: May 11 Filed by: Rivas Maria
Entities mentioned with TLX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Earnings | View Related Stories »
- Show More...
